The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
暂无分享,去创建一个
[1] R. Jones. Changing patterns of resistance to new beta-lactam antibiotics. In vitro efficacy of cefoperazone against bacterial pathogens. , 1984, The American journal of medicine.
[2] R. Jones,et al. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates , 1984, Antimicrobial Agents and Chemotherapy.
[3] R. Jones,et al. Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks , 1984, Journal of clinical microbiology.
[4] R. Jones,et al. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics. , 1983, Reviews of infectious diseases.
[5] R. Jones,et al. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity. , 1982, Reviews of infectious diseases.
[6] M. Crosby,et al. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production , 1982, Antimicrobial Agents and Chemotherapy.
[7] R. Jones,et al. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits , 1982, Journal of clinical microbiology.
[8] R. Jones,et al. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone , 1982, Journal of clinical microbiology.
[9] J. Washington,et al. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae. , 1981, Antimicrobial Agents and Chemotherapy.
[10] R. Fass. Inconsistency of Synergy Between the β-Lactamase Inhibitor CP-45,899 and β-Lactam Antibiotics Against Multiply Drug-Resistant Enterobacteriaceae and Pseudomonas Species , 1981, Antimicrobial Agents and Chemotherapy.
[11] V. .. D. Bene,et al. InVitro Activity ofN-Formimidoyl Thienamycin, Moxalactam, andOtherNewBeta-Lactam Agents Against Bacteroides fragilis: Contribution ofBeta-Lactamase to , 1981 .
[12] R. Jones,et al. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. , 1981, The Journal of antimicrobial chemotherapy.
[13] R. Pearson,et al. Method of reliable determination of minimal lethal antibiotic concentrations , 1980, Antimicrobial Agents and Chemotherapy.
[14] C. O'callaghan,et al. Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections , 1980, Antimicrobial Agents and Chemotherapy.
[15] R. Jones,et al. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin , 1980, Antimicrobial Agents and Chemotherapy.
[16] A. R. English,et al. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides , 1980, Antimicrobial Agents and Chemotherapy.
[17] S. Mitsuhashi,et al. Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins , 1980, Antimicrobial Agents and Chemotherapy.
[18] R. Jones,et al. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains , 1980, Antimicrobial Agents and Chemotherapy.
[19] R. Wise,et al. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. , 1980, The Journal of antimicrobial chemotherapy.
[20] S. Mitsuhashi,et al. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin , 1979, Antimicrobial Agents and Chemotherapy.
[21] C. Metzler,et al. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. , 1974, The Journal of infectious diseases.
[22] R. Sykes,et al. The beta-lactamases of gram-negative bacteria and their possible physiological role. , 1973, Advances in microbial physiology.